Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

evergrowth pty ltd - propolis resin, quantity: 200 mg/ml (equivalent: lead, qty 2 microgram/ml; equivalent: propolis, qty 300 mg/ml) - liquid, multipurpose - excipient ingredients: propylene glycol - antioxidant/reduce free radicals formed in the body ; maintain/support general health and wellbeing ; decrease/reduce/relieve symptoms of mild mouth ulcers ; traditionally used in chinese medicine to decrease/reduce/relieve mild throat inflammation ; traditionally used in western herbal medicine to decrease/reduce/relieve mild throat inflammation ; decrease/reduce/relieve mild throat inflammation ; traditionally used in chinese medicine to decrease/reduce/relieve symptoms of mild throat infection ; traditionally used in western herbal medicine to decrease/reduce/relieve symptoms of mild throat infection ; decrease/reduce/relieve throat mucous membrane irritation/inflammation ; helps decrease/reduce/relieve symptoms of minor skin wounds (cuts, scratches and abrasions) ; traditionally used in western herbal medicine to maintain/support wound healing ; traditionally used in chinese medicine to maintain/support wound healing

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

h c l manufacturers pty ltd - propolis dry extract -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - warfarin sodium, quantity: 2 mg - tablet, uncoated - excipient ingredients: lactose; magnesium stearate; maize starch; stearic acid; amaranth aluminium lake; indigo carmine aluminium lake - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation. coumadin is not indicated in patients with lone atrial fibrillation who are less than 60 years of age with no risk factors (eg previous thromboembolism (tia, ischaemic stroke), diabetes mellitus, hypertension) and an otherwise normal heart. coumadin is indicated for use as an adjunct in the treatment of coronary occlusion.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - warfarin sodium, quantity: 1 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; maize starch; pregelatinised maize starch; indigo carmine; iron oxide yellow; iron oxide red; sodium starch glycollate; magnesium stearate - marevan is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension and pulmonary embolism. marevan is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation. marevan is not indicated in patients with lone atrial fibrillation who are less than 60 years of age with no risk factors (eg previous thromboembolism (tia, ischaemic stroke), diabetes mellitus, hypertension) and an otherwise normal heart. marevan is indicated for use as an adjunct in the treatment of coronary occlusion.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

evalar pty ltd - anethum graveolens,senna alexandrina,zingiber officinale -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

australian united pharmaceuticals pty ltd - ascorbic acid,senna alexandrina,vaccinium macrocarpon,vaccinium myrtillus,vitis vinifera -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - senna alexandrina, quantity: 41.2 mg (equivalent: senna alexandrina, qty 700.4 mg; equivalent: hydroxyanthracene glycosides calculated as sennoside b, qty 8.24 mg) - tablet, film coated - excipient ingredients: docusate sodium; magnesium stearate; sodium benzoate; calcium carbonate; crospovidone; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black; lecithin - decrease/reduce/relieve constipation

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

australian united pharmaceuticals pty ltd - ascorbic acid,senna alexandrina,vaccinium macrocarpon,vaccinium myrtillus,vitis vinifera -

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

wai shun pty ltd - camellia sinensis, quantity: 67.5 mg (equivalent: camellia sinensis, qty 675 mg; equivalent: caffeine, qty 25 mg); astragalus membranaceus, quantity: 108 mg (equivalent: astragalus membranaceus, qty 540 mg); crataegus pinnatifida, quantity: 101.2 mg (equivalent: crataegus pinnatifida, qty 404.8 mg); nelumbo nucifera, quantity: 33.7 mg (equivalent: nelumbo nucifera, qty 674 mg); senna alexandrina, quantity: 139.6 mg (equivalent: senna alexandrina, qty 404.8 mg; equivalent: hydroxyanthracene glycosides calculated as sennoside b, qty 10.115 mg) - capsule, hard - excipient ingredients: gelatin - maintain/support calorie burning ; helps maintain/support healthy cholesterol ; traditionally used in chinese medicine to aid/assist/helps elimination of dietary fat

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

vitex pharmaceuticals pty ltd - senna alexandrina, quantity: 50 mg (equivalent: senna alexandrina, qty 500 mg; equivalent: hydroxyanthracene glycosides calculated as sennoside b, qty 10 mg) - tablet, film coated - excipient ingredients: carnauba wax; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; croscarmellose sodium; calcium hydrogen phosphate; purified talc; iron oxide red; macrogol 3000; polyvinyl alcohol - maintain/support general health and wellbeing ; maintain/support healthy bowel/colon function